Antileukemic activity of nuclear export inhibitors that spare normal hematopoietic cells-Reference-Cited by-同舟云学术

Antileukemic activity of nuclear export inhibitors that spare normal hematopoietic cells

Published:2012-07-31 Issue:1 Volume:27 Page:66-74
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Etchin J,Sun Q,Kentsis A,Farmer A,Zhang Z C,Sanda T,Mansour M R,Barcelo C,McCauley D,Kauffman M,Shacham S,Christie A L,Kung A L,Rodig S J,Chook Y M,Look A T

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/leu2012219.pdf

Reference38 articles.

1. Turner JG, Dawson J, Sullivan DM . Nuclear export of proteins and drug resistance in cancer. Biochem Pharmacol 2012; 83: 1021–1032.

2. Fornerod M, Ohno M, Yoshida M, Mattaj IW . CRM1 is an export receptor for leucine-rich nuclear export signals. Cell 1997; 90: 1051–1060.

3. Fukuda M, Asano S, Nakamura T, Adachi M, Yoshida M . CRM1 is responsible for intracellular transport meditted by the nuclear export signal. Nature 1997; 390: 308–311.

4. Ossareh-Nazari B, Bachelerie F, Dargemont C . Evidence for a role of CRM1 in signal-mediated nuclear protein export. Science 1997; 278: 141–144.

5. Stade K, Ford CS, Guthrie C, Weis K . Exportin 1 (Crm1p) is an essential nuclear export factor. Cell 1997; 90: 1041–1050.

Cited by 165 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. RHOF activation of AKT/β-catenin signaling pathway drives acute myeloid leukemia progression and chemotherapy resistance;iScience;2024-07

2. Impact of structural biology and the protein data bank on us fda new drug approvals of low molecular weight antineoplastic agents 2019–2023;Oncogene;2024-06-17

3. The nuclear export protein exportin‐1 in solid malignant tumours: From biology to clinical trials;Clinical and Translational Medicine;2024-05

4. Tackling the Moving Mutant Target: Taxifolin Derivatives as Novel Putative E571K Exportin-1 Inhibitors for KRAS-mutant Lung Adenocarcinoma;2024 International Conference on Science, Engineering and Business for Driving Sustainable Development Goals (SEB4SDG);2024-04-02

5. Identifying novel inhibitors targeting Exportin-1 for the potential treatment of COVID-19;Archives of Microbiology;2024-01-19